QI
DVAX

Qtron Investments’s Dynavax Technologies DVAX Stock Holding History

Qtron Investments’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,255
Closed -$121K – 316
2021
Q2 		$121K Buy
+12,255
New +$111K 0.03% 335

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Qtron Investments's DVAX Position: Q3 2021 in Review

Qtron Investments sold out of Dynavax Technologies (DVAX) in Q3 2021, closing a stake of 12,255 shares — an estimated $121K sold.

Qtron Investments first reported a position in DVAX in Q2 2021 and held it in 1 quarter. The position peaked at $121K in Q2 2021. 183 funds tracked by Wall St. Rank hold DVAX as of Q3 2021.

  • Qtron Investments reported no remaining Dynavax Technologies position as of Q3 2021 after selling out during the quarter.
  • Qtron Investments sold 12,255 Dynavax Technologies shares in Q3 2021, an estimated $121K.
  • Qtron Investments first reported a position in Dynavax Technologies in Q2 2021 and held it in 1 quarter.
  • Qtron Investments's Dynavax Technologies position peaked at $121K in Q2 2021.
  • 183 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2021.

Based on Qtron Investments's 13F filing for Q3 2021, filed 12 Nov 2021.